Editorial: Emerging Therapies for Malignant Mesothelioma

• Nico van Zandwijk,
• Glen Reid,
• Paul Baas

Affiliations

Nico van Zandwijk

Concord Repatriation General Hospital, Sydney Local Health District/University of Sydney, Concord, NSW, Australia

Glen Reid

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand

Paul Baas

Department of Thoracic Oncology, Netherland Cancer Institute, Amsterdam, Netherlands